Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regen BioPharma (RGBP) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Regen BioPharma (RGBP) over the last 11 years, with Q4 2025 value amounting to 0.69.

  • Regen BioPharma's Asset Utilization Ratio fell 4831.23% to 0.69 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.69, marking a year-over-year decrease of 4831.23%. This contributed to the annual value of 1.09 for FY2025, which is 1812.92% up from last year.
  • Per Regen BioPharma's latest filing, its Asset Utilization Ratio stood at 0.69 for Q4 2025, which was down 4831.23% from 1.0 recorded in Q3 2025.
  • In the past 5 years, Regen BioPharma's Asset Utilization Ratio ranged from a high of 1.58 in Q1 2024 and a low of 0.13 during Q3 2021
  • Its 5-year average for Asset Utilization Ratio is 0.79, with a median of 0.69 in 2023.
  • As far as peak fluctuations go, Regen BioPharma's Asset Utilization Ratio plummeted by 8713.76% in 2021, and later skyrocketed by 19149.05% in 2022.
  • Over the past 5 years, Regen BioPharma's Asset Utilization Ratio (Quarter) stood at 0.21 in 2021, then skyrocketed by 132.36% to 0.48 in 2022, then soared by 90.48% to 0.92 in 2023, then skyrocketed by 45.57% to 1.34 in 2024, then tumbled by 48.31% to 0.69 in 2025.
  • Its Asset Utilization Ratio stands at 0.69 for Q4 2025, versus 1.0 for Q3 2025 and 1.29 for Q2 2025.